{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:43:18Z","timestamp":1773722598440,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research: Cognition"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.scog.2020.100173","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T06:24:33Z","timestamp":1583130273000},"page":"100173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study"],"prefix":"10.1016","volume":"20","author":[{"given":"Gahan","family":"Pandina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Nuamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskaran","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.scog.2020.100173_bb0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/chi.0b013e318054678d","article-title":"Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome","volume":"46","author":"Cervellione","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.scog.2020.100173_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.scog.2020.100173_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/YIC.0b013e328314e1f3","article-title":"Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies","volume":"23","author":"Emsley","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.scog.2020.100173_bb0020","first-page":"583","article-title":"Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study","volume":"49","author":"Findling","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"5","key":"10.1016\/j.scog.2020.100173_bb0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jaac.2012.02.001","article-title":"Neurocognitive outcomes in the treatment of early-onset schizophrenia spectrum disorders study","volume":"51","author":"Frazier","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.scog.2020.100173_bb0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jamapsychiatry.2013.4190","article-title":"Neurocognitive growth charting in psychosis spectrum youths","volume":"71","author":"Gur","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.scog.2020.100173_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjp.bp.107.046177","article-title":"Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study","volume":"194","author":"Haas","year":"2009","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"6","key":"10.1016\/j.scog.2020.100173_bb0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/YIC.0b013e32833db3d8","article-title":"Tolerability of paliperidone: a meta-analysis of randomized, controlled trials","volume":"25","author":"Harrington","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.scog.2020.100173_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2014.04.014","article-title":"Relative stability of neurocognitive deficits in early onset schizophrenia spectrum patients","volume":"156","author":"Juuhl-Langseth","year":"2014","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.scog.2020.100173_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.scog.2020.100173_bb0055","first-page":"77","article-title":"A Swedish National prospective and co-relative study of school achievement at age 16, and risk for schizophrenia, other nonaffective psychosis, and bipolar illness","volume":"42","author":"Kendler","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"2\u20133","key":"10.1016\/j.scog.2020.100173_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-9964(03)00067-7","article-title":"The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia","volume":"65","author":"Kravariti","year":"2003","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.scog.2020.100173_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.01.009","article-title":"Cognitive decline in schizophrenia from childhood to midlife: a 33-year longitudinal birth cohort study","volume":"118","author":"Kremen","year":"2010","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.scog.2020.100173_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/2013.jamapsychiatry.43","article-title":"Decline in cognitive performance between ages 13 and 18 years and the risk for psychosis in adulthood: a Swedish longitudinal cohort study in males","volume":"70","author":"MacCabe","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.scog.2020.100173_bb0075","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopsych.2007.01.017","article-title":"Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study","volume":"62","author":"Marder","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.scog.2020.100173_bb0080","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4088\/JCP.v69n0515","article-title":"Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies","volume":"69","author":"Meltzer","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.scog.2020.100173_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.schres.2006.02.005","article-title":"Neurocognitive performance and functional disability in the psychosis prodrome","volume":"84","author":"Niendam","year":"2006","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.scog.2020.100173_bb0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijdevneu.2010.10.003","article-title":"Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder","volume":"29","author":"Rapoport","year":"2011","journal-title":"International Journal of Developmental Neuroscience: the official journal of the International Society for Developmental Neuroscience"},{"issue":"2","key":"10.1016\/j.scog.2020.100173_bb0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","article-title":"Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study","volume":"167","author":"Reichenberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.scog.2020.100173_bb0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/cap.2014.0130","article-title":"Long-term safety of paliperidone extended release in adolescents with schizophrenia: an open-label, flexible dose study","volume":"25","author":"Savitz","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1016\/j.scog.2020.100173_bb0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaac.2014.11.009","article-title":"Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study","volume":"54","author":"Savitz","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"12","key":"10.1016\/j.scog.2020.100173_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.biopsych.2011.06.021","article-title":"A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents","volume":"70","author":"Singh","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.scog.2020.100173_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13651501.2013.845218","article-title":"The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial","volume":"18","author":"Suzuki","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."}],"container-title":["Schizophrenia Research: Cognition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215001319300289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215001319300289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T05:46:51Z","timestamp":1762408011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215001319300289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"alternative-id":["S2215001319300289"],"URL":"https:\/\/doi.org\/10.1016\/j.scog.2020.100173","relation":{},"ISSN":["2215-0013"],"issn-type":[{"value":"2215-0013","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research: Cognition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scog.2020.100173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Janssen Research & Development, LLC. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100173"}}